AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
10.84
+0.20 (1.88%)
At close: Mar 31, 2025, 4:00 PM
10.86
+0.02 (0.17%)
After-hours: Mar 31, 2025, 6:18 PM EDT
AdaptHealth Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for AdaptHealth stock have an average target of 13.8, with a low estimate of 11 and a high estimate of 16. The average target predicts an increase of 27.31% from the current stock price of 10.84.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 27, 2025.
Analyst Ratings
The average analyst rating for AdaptHealth stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $14 → $16 | Buy | Maintains | $14 → $16 | +47.60% | Feb 27, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +29.15% | Feb 26, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $11 → $14 | Buy | Maintains | $11 → $14 | +29.15% | Feb 26, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $12 → $14 | Strong Buy | Maintains | $12 → $14 | +29.15% | Feb 26, 2025 |
| UBS | UBS | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +1.48% | Feb 13, 2025 |
Financial Forecast
Revenue This Year
3.33B
from 3.26B
Increased by 2.21%
Revenue Next Year
3.49B
from 3.33B
Increased by 4.83%
EPS This Year
0.89
from 0.61
Increased by 45.48%
EPS Next Year
1.04
from 0.89
Increased by 17.47%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.5B | 3.7B | 3.9B |
| Avg | 3.3B | 3.5B | 3.7B |
| Low | 3.2B | 3.3B | 3.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.1% | 11.3% | 11.4% |
| Avg | 2.2% | 4.8% | 4.6% |
| Low | -2.9% | -1.9% | -2.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.16 | 1.45 | 1.63 | ||
| Avg | 0.89 | 1.04 | 1.30 | ||
| Low | 0.60 | 0.80 | 0.99 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 89.3% | 63.3% | 56.1% | ||
| Avg | 45.5% | 17.5% | 24.3% | ||
| Low | -2.0% | -9.4% | -5.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.